A phase 3 study of Pamrevlumab to treat patients with idiopathic pulmonary fibrosis (IPF).
Phase of Trial: Phase III
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Pamrevlumab (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 07 Aug 2018 According to a FibroGen media release, this study is planned to begin early in 2019.
- 08 Mar 2018 New trial record